Form4insider filings, from the source

SEC Form 4 · accession 0001562180-19-001473

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 25, 2019S500$161.00D72,400ISee footnote (2)
Common StockFeb 25, 2019S500$161.00D71,900ISee footnote (3)
Common StockFeb 25, 2019S500$161.00D71,400ISee footnote (4)
Common StockFeb 25, 2019S500$161.00D70,900ISee footnote (5)
Common StockFeb 25, 2019G122,400$0.00D119,295ISee footnote (6)
Common StockFeb 25, 2019G30,600$0.00A101,500ISee footnote (7)
Common StockFeb 25, 2019G30,600$0.00A132,100ISee footnote (8)
Common StockFeb 25, 2019G30,600$0.00A162,700ISee footnote (9)
Common StockFeb 25, 2019G30,600$0.00A193,300ISee footnote (10)
Common Stockholding———272,777D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses